• Explore /
  • Poster
  • / A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with <em>BRCA1/2</em> gene alterations (NePtune).

A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune).

Abstract Poster

Authors

null

Rana R. McKay

University of California, San Diego, La Jolla, CA

Rana R. McKay , Lin Liu , Minya Pu , Arlene Araneta , Luke Wang , Neremiah Castano , Jennifer Gomez , Archana Ajmera , Huihui Ye , Roberto Pili , Karie Runcie , Deaglan Joseph McHugh , Kenneth Offit , Channing Judith Paller , Naomi B. Haas , Juan Javier-Desloges , Christopher J. Kane , Tyler M Seibert , Aditya Bagrodia

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05498272

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr TPS353)

DOI

10.1200/JCO.2024.42.4_suppl.TPS353

Abstract #

TPS353

Poster Bd #

R5

Abstract Disclosures

Similar Posters

First Author: Rana R. McKay

First Author: Yao Zhu

First Author: Emmanuel S. Antonarakis

First Author: Rana R. McKay